Find a trial

Our clinical trials database will help you look for a clinical trial that might be suitable for you. We hope this helps you to make informed decisions and choices about your lymphoma treatment and care. 

Questions about Lymphoma TrialsLink and how to use it? Read more about Lymphoma TrialsLink here or if you have a general question about clinical trials in the UK or Lymphoma TrialsLink, please contact us at trialslink@lymphoma-action.org.uk.

Note: We are not able to refer people to specific trials. If you’re interested in taking part in a trial you have found on Lymphoma TrialsLink, we recommend that you print the trial summary and discuss it with your consultant. They can advise you on whether you might be eligible for the trial and how you can take part based on your individual circumstances.

Trial name Closing date

EPCORE FL-2: A phase 3 trial of epcoritamab with rituximab and lenalidomide in people with untreated follicular lymphoma

ALLCAR19: A phase 1 trial of CAR T-cell therapy in adults with relapsed or refractory DLBCL, CLL, SLL, FL or MCL

BELLWAVE-010: A phase 3 trial of nemtabrutinib and venetoclax in people with relapsed or refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma

BGB-3111 CLL: a phase 3 trial of sonrotoclax (BGB-11417) plus zanubrutinib in people with chronic lymphocytic leukaemia

Bellwave-011: A phase 3 trial of nemabrutinib in people with chronic lymphocytic leukaemia or small lymphocytic lymphoma

RADAR: A phase 3 trial of an antibody treatment called brentuximab vedotin in people with early stage Hodgkin lymphoma

REFRACT: A phase 2 trial comparing new treatments to standard treatment in relapsed or refractory follicular lymphoma

OASIS II: A phase 2 trial of potential treatment regimens in people with mantle cell lymphoma

Glo-BNHL: a phase 2 and 3 trial testing odronextamab and loncastuximab tesirine in young people with relapsed or refractory B-cell non-Hodgkin lymphoma

Zuma-22: A trial testing axicabtagene ciloleucel in people with relapsed or refractory follicular lymphoma

Mahogany: A phase 3 trial of zanubrutinib and anti-CD20 in people with relapsed or refractory follicular or marginal zone lymphoma

RAINBOW: a randomised, phase 2/3 trial comparing ibrutinib plus rituximab with standard treatment in people with Waldenström’s macroglobulinaemia

EPCORE DLBCL-2: A phase 3 trial looking at the medication epcoritamab in people with DLBCL

ELM-2: a phase 2 trial assessing the safety of odronextamab in adults with relapsed or refractory B-cell non-Hodgkin lymphoma

BO43243: A phase 1 trial of mosunetuzumab in relapsed or refractory chronic lymphocytic leukaemia (CLL)

OLYMPIA-5: A phase 3 trial of odronextamab in people with relapsed or refractory follicular or marginal zone lymphoma

Determine trial treatment arm 1: A phase 2/3 trial of alectinib in people with ALK positive lymphomas

EPCORE CLL-1: A trial testing epcoritamab in people with relapsed or refractory chronic lymphocytic leukaemia and Richter’s syndrome

OLYMPIA-2: A phase 3 trial of odronextamab in people with relapsed or refractory follicular lymphoma

Athena 1: A phase 1 study of REGN5837 in people with relapsed or refractory B-cell non-Hodgkin lymphomas

EBV: A phase 2 trial of tabelecleucel in people with Epstein-Barr virus associated diseases

RITZ: a phase 3 trial testing zanubrutinib with rituximab in adults with untreated splenic marginal zone lymphoma

ABBV-101: A phase 1 trial of ABBV-101 in people with relapsed or refractory B-cell lymphomas

OLYMPIA-1: A phase 3 trial of odronextamab in people with untreated follicular lymphoma

LIGHTBEAM-U01 (substudy 01A): a phase 1 and 2 trial testing zilovertamab vedotin in young people with relapsed or refractory DLBCL or Burkitt lymphoma

CO43805: A Phase 1b trial of mosunetuzumab or glofitamab in people with B-cell Non-Hodgkin Lymphoma

SYMPHONY-1: a phase 1b/3 double-blind, randomised study of tazemetostat or placebo in combination with lenalidomide plus rituximab in subjects with relapsed/refractory follicular lymphoma

GO44145: A phase 3 trial of glofitamab and Pola-R-CHP in people with B-cell lymphoma

ReVenG: A phase 2 trial of venetoclax and obinutuzumab in people with relapsed chronic lymphocytic leukaemia

GOLSEEK-2: A phase 2 trial testing golcadomide with rituximab in adults with newly diagnosis advanced follicular lymphoma

MK-3475A-F65: A phase 2 trial of pembrolizumab (MK-3475) in people with relapsed or refractory classical Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

ZEBRA: a phase 2 trial of zanubrutinib and rituximab in people with mantle cell lymphoma

OLYMPIA-3: A phase 3 trial of odronextamab in people with diffuse large B-cell lymphoma

STATIC: A study comparing intermittent and continuous treatment with ibrutinib in CLL/SLL

BGB-11417 (WM): A phase 2 trial of BGB-11417 in people with relapsed or refractory Waldenstrom’s Macroglobulinaemia

OptiMATe: A phase 3 trial to optimise the MATRix chemotherapy regimen in primary central nervous system lymphoma

PORTAL: a phase 2 trial testing polatuzumab vedotin, obinutuzumab and glofitamab in adults with relapsed or refractory large B-cell lymphoma

RELATIVITY-069: A phase 1/2 trial of relatlimab plus nivolumab in children and young adults with relapsed or refractory classic Hodgkin and Non-Hodgkin lymphoma

LOTIS-5: A phase 3 trial of loncastuximab tesirine and rituximab in people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

BGB-16673: A phase 1 and 2 trial of BGB-16673 in people with B-cell lymphomas

ALETA-001: A phase 1 and 2 trial of ALETA-001 in patients with relapsed or refractory non-Hodgkin lymphoma

JNJ-90014496: A phase 1 trial of JNJ-90014496 in people with relapsed or refractory B-cell non-Hodgkin lymphoma

waveLINE-003: A trial testing zilovertamab vedotin (MK-2140) in people with relapsed or refractory diffuse large B-cell lymphoma

BGB-11417 (BCL): A phase 1 trial of BGB-11417 in people with B cell malignancies

REMoDL-A: A phase 2 trial of a targeted drug called acalabrutinib added to standard treatment for people with diffuse large B-cell lymphoma

ABBV-525: A phase 1 trial of ABBV-525 in people with B-cell lymphomas

ALLELE: A phase 3 trial of a targeted treatment called tabelecleucel in people with post-transplant lymphoproliferative disorder

STELLAR: a phase 2 trial of acalabrutinib in people with Richter syndrome

JNJ-90009530: A phase 1 trial of JNJ-90009530 in people with relapsed or refractory B-cell Non-Hodgkin lymphoma

MK-2140-006: A trial testing zilovertamab vedotin in people with selected B-cell lymphoma

CC-99282: A phase 1 trial of CC-99282 alone and in combination with anti-lymphoma agents in people with relapsed or refractory non-Hodgkin lymphoma

PRO-CAR-T: A study to design and test a tool to gather information from patients after CAR-T therapy

MK-1026: A phase 2 trial of nemabrutinib (MK-1026) in people with certain types of relapsed or refractory non-Hodgkin lymphoma

EPCORE DLBCL-3: A phase 3 trial of epcoritamab with or without lenalidomide in patients with diffuse large B-cell lymphoma

PROCLIPI: a study aiming to identify factors important in predicting the outcome of cutaneous (skin) lymphomas, mycosis fungoides and Sezary syndrome

CAN3001: A long term study of ibrutinib

NX-5948-301: A phase 1 study of a new treatment called NX-5948 in adults with relapsed or refractory B-cell lymphoma

MOGAT: A phase 2 trial of mogamulizumab in cutaneous T-cell lymphoma

GLOBRYTE: A phase 3 trial of glofitamab in people with relapsed or refractory mantle cell lymphoma

PRiZM+: A phase 1 trial of zanubrutinib in people with relapsed or refractory primary central nervous system lymphoma

JNJ-80948543: A phase 2 trial testing JNJ-80948543 in adults with relapsed and refractory DLBCL

MAST: A trial investigating the link between gut health and stem cell transplant outcomes in patients with chronic lymphocytic leukaemia

NuTide:701: a phase 1 trial to find the best dose and test the safety of a new drug called NUC-7738 in people with advanced solid tumours or lymphoma

Kite: A trial testing KITE-363 and KITE-753 in people with relapsed and refractory B-cell lymphoma

PRIMAVERA: a phase 1/2 trial testing AZD3470 in people with relapsed or refractory lymphoma

PRT2527: a phase 1 trial of PRT2527 in people with relapsed or refractory B-cell lymphomas

CPI-0209: A study of CPI-0209 in relapsed or refractory diffuse large B-cell and peripheral T-cell lymphomas

NX-1607: A phase 1 study of NX-1607 in adults with advanced solid tumours

MoTD: A phase 2 trial comparing interventions for the prevention of graft versus host disease after unrelated donor stem cell transplantation.

STP938: A phase 1/2 study of STP938 for adults with relapsed or refractory B-cell and T-cell lymphomas

BOOST: studying samples from stem cell transplant donors and recipients to improve transplant success rates and reduce side effects

NVG-111: a phase 1/2 trial of NVG-111 in relapsed or refractory chronic lymphocytic leukaemia, small lymphocytic lymphoma and mantle cell lymphoma

KB-0742: A phase 1 and 2 trial of KB-0742 in people with relapsed or refractory non-Hodgkin lymphoma

BYON4228: A phase 1 trial of BYON4228 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

TRuST: A phase 1 and 2 trial to assess the long-term safety of the tazemetostat

PETReA: a trial testing whether PET scans can help make treatment decisions for people with follicular lymphoma

BASILICA-A: A study into why anaplastic large cell lymphoma sometimes occurs after breast implants

DIRECT: A study looking at genetic changes in diffuse large B-cell lymphoma and other types of high-grade B-cell lymphoma

CCS1477-02: a phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma

DTP3: A phase 1/2 trial of DTP3 in people with relapsed or refractory diffuse large B cell lymphoma (DLBCL)

WaveLINE-006: a phase 2 trial testing zilovertamab vedotin in adults with relapsed or refractory B-cell lymphoma